Back
Skye Bioscience, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
18
SKYE
Skye Bioscience, Inc.
Last Price:
$1.24
Seasonality Move:
-20.14%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiSkye Bioscience, Inc. Stock Forecast
-
Is Skye Bioscience, Inc. Stock Undervalued?The current Skye Bioscience, Inc. [SKYE] share price is $1.21. The Score for SKYE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
SKYE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Skye Bioscience, Inc. Stock Go Up Next Year?
Data Unavailable
Skye Bioscience, Inc. Stock Rating
Data Unavailable
Skye Bioscience, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
skyebioscience.com
52-Week Data
52-Week High:
5.75
52-Week Low:
1.10
Prediction Charts
Market Cap:
38.8M
Price in USD:
1.21
Volume:
165.1K
Beta:
1.53
Technical Analysis
SMA50:
1.82
SMA100:
2.76
SMA200:
2.58
52-Wk Change:
-68.57%
Stock Predictions
-
Is Skye Bioscience, Inc. stock public?Yes, Skye Bioscience, Inc. is a publicly traded company.
-
What is the Skye Bioscience, Inc. stock quote today?The Skye Bioscience, Inc. stock price is 1.21 USD today.
-
How to buy Skye Bioscience, Inc. stock online?You can buy Skye Bioscience, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.33 | 1.30 | 1.40 | 1.28 |
| Nov-17 | 1.38 | 1.40 | 1.46 | 1.36 |
| Nov-18 | 1.36 | 1.33 | 1.40 | 1.33 |
| Nov-19 | 1.33 | 1.31 | 1.37 | 1.30 |
| Nov-20 | 1.31 | 1.25 | 1.35 | 1.25 |
| Nov-21 | 1.25 | 1.17 | 1.28 | 1.16 |
| Nov-24 | 1.18 | 1.30 | 1.32 | 1.18 |
| Nov-25 | 1.31 | 1.28 | 1.34 | 1.26 |
| Nov-26 | 1.28 | 1.31 | 1.36 | 1.28 |
| Nov-28 | 1.35 | 1.31 | 1.38 | 1.31 |
| Dec-1 | 1.28 | 1.21 | 1.30 | 1.21 |
| Dec-2 | 1.22 | 1.11 | 1.23 | 1.10 |
| Dec-3 | 1.15 | 1.22 | 1.24 | 1.14 |
| Dec-4 | 1.23 | 1.21 | 1.24 | 1.18 |
Skye Bioscience, Inc. Earnings
Data Unavailable
Skye Bioscience, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and an increase next year of $0.22 per share.
* Skye Bioscience, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.